We aimed to conduct a meta-analysis of serious adverse events (macro-and micro-vascular events, falls and fractures, death) associated with hypoglycaemia in older patients.
Introduction
Diabetes is major chronic disease, affecting millions of people worldwide. In the UK, it is seen in 10-25% of older people and is often associated with other comorbidities, such as cardiovascular disease and cognitive impairment (Sinclair et al., 2001 ). Hamada et al found that 28% of over 80-year olds in the UK had co-morbid diabetes and cardiovascular disease and 5% had co-morbid diabetes and cognitive impairment/dementia (Hamada and Gulliford, 2015) . This vulnerable group of people is also at an increased risk of falls (Schwartz et al., 2008) , which result in an estimated £1.1billion in hospital costs annually from hip fractures in the UK (Leal et al., 2015) .
Hypoglycaemia is a well-recognised side effect of diabetes treatment and concerns have been raised about potentially serious consequences of hypoglycaemia on the cardiovascular system and cognition in older people (Frier et al., 2011) (Mattishent and Loke, 2015) . Bloomfield et al found evidence for an association between severe hypoglycaemia and all-cause mortality, neurological events, hospital and emergency department utilization and decreased quality of life, but there was insufficient data on cardiovascular disease, falls and traumatic injuries (Bloomfield et al., 2012) . More recent evidence has since emerged from an observational study reporting an association between hypoglycaemia and falls, whilst a meta-analysis of six studies revealed a significantly increased likelihood of cardiovascular disease associated with severe hypoglycaemia (Chiba et al., 2015) (Goto et al., 2013) .
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In light of these recent developments, we aimed to systematically review and analyze contemporary evidence on the relationship between hypoglycaemia and adverse events (vascular events, falls and fractures, death) in older patients treated with glucose lowering drugs. We focused on vascular adverse events because patients with diabetes have an increased risk of micro-and macro-vascular disease (Bloomfield et al., 2012) and cardiovascular events remains the primary cause of death among insulin-treated people with diabetes (Khunti et al., 2015) . We also aimed to evaluate falls and fractures because injuries are a leading cause of death in older people and can result in significant physical, psychological and social consequences (Thapa et al., 1996) .
Material and Methods

Data sources and searches
Our database search covered MEDLINE and EMBASE for 10 years up to March 2015 (details of the search are provided in the supplementary eMethods), restricted to English language articles. The search was focused on the last 10 years, as we wanted more recent studies based on contemporary practice and populations. In addition, we received PubMed automated updates (most recent October 2015) regarding newly published articles on hypoglycaemia in older patients. We reviewed the reference lists of included studies for any potentially relevant studies.
Study selection
We specified inclusion criteria for cohort studies (prospective and retrospective), that examined the association between hypoglycaemia and serious adverse events.
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We included studies that enrolled participants aged >55 years who had pre-diabetes or diabetes mellitus. The outcomes of interest were macro-and micro-vascular events, fall, fractures, and death. We excluded reviews and abstracts.
Data extraction and quality assessment
Study screening and data extraction was performed by the authors, by independently scanning all titles and abstracts for relevant articles, before obtaining full text versions for further checking. YKL and KM resolved uncertainties and discrepancies through discussion.
Data collection was completed by using a standardized form, which included details of the study design, date of the study and country of origin, setting, selection criteria, participants' characteristics and outcome measures. Odds or hazard ratios were extracted as a measure of the association between hypoglycaemia and adverse events.
In order to assess study validity, YKL and KM independently checked the methods used for recording hypoglycaemia and determining serious adverse events, as well as adjustment for potential confounding factors.
Data synthesis and analysis
A random effects meta-analysis of odds ratios using inverse variance method (Revman 5.3, Nordic Cochrane Centre, Kobenhavn) was performed. Heterogeneity was assessed by using the chi-squared test, I 2 statistic and visual inspection of the M A N U S C R I P T
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Results
We screened 1273 citations and included 17 studies with a total of 1498358 participants in the meta-analysis (Bonds et al., 2010 , Chiba et al., 2015 , Duckworth et al., 2011 , Hsu et al., 2013 , Origin Trial Investigators et al., 2013 , Johnston et al., 2012 , Johnston et al., 2011 , Khunti et al., 2015 , Majumdar et al., 2013 , McCoy et al., 2012 , Rajpathak et al., 2015 , Rathmann et al., 2013 , Signorovitch et al., 2013 , Zhao et al., 2012 , Zoungas et al., 2010 . The flow chart of the study selection in shown in the supplementary eFigure. Characteristics of the included studies and participants are shown in the supplementary eTable.
The included studies consisted of twelve retrospective, one prospective and four post-hoc analyses of randomized controlled trials (RCTs). The studies had a total of participants (sample size from 211 to 860,845). Geographical locations were diverse and included North America, Japan, Taiwan and Europe. All the included studies were conducted in older patients (mean age >60 years, or participants selected on basis of being 60 years of age or older).
Thirteen studies focused on patients with Type 2 diabetes, whereas the remaining four had a mix of Type 1, Type 2 and impaired glucose tolerance/impaired fasting glucose. Four of the studies looked only at oral agents. The remaining studies included insulin users as well as patients on oral antidiabetic drugs (or a mix of insulin and tablets).
We report details of study validity (ascertainment of adverse outcomes, and confounding factors) in Table 1 , and summarize the key features below.
Measurement of hypoglycemic events
Most of the studies relied on hospital or claims data records. Two studies provided participants with diaries and glucose meters (Origin Trial Investigators et al., 2013 ) (Bonds et al., 2010) and two studies relied on questionnaires (Chiba et al., 2015) ( McCoy et al., 2012) . Two of the studies relied on routine trial monitoring (Duckworth et al., 2011 ) (Zoungas et al., 2010 .
Measurement of adverse events
Four of the included studies used pre-specified outcomes from RCTs with independent adjudication by a blinded committee. Twelve studies measured adverse events through database or medical records codes and one study relied on a professional interviewer with questionnaire (Chiba et al., 2015) .
Confounding factors
All studies attempted to address confounding through the use of multiple logistic regression models, and in addition three studies used Propensity Scores (Hsu et al., 2013 ) (Origin Trial Investigators et al., 2013 , Zhao et al., 2012 .
Meta-analysis
Association between hypoglycaemia and vascular disease (Figure 1) We included eight studies in the meta-analysis for macrovascular complications (Duckworth et al., 2011 , Hsu et al., 2013 , Johnston et al., 2011 , Khunti et al., 2015 , Rathmann et al., 2013 , Zhao et al., 2012 , Zoungas et al., 2010 There are two studies in the meta-analysis which reported on the association between hypoglycaemia and microvascular complications (Zhao et al., 2012 , Zoungas et al., 2010 . The pooled odds ratio was 1.77 (95% Confidence Interval 1.49, 2.10) with no evidence of heterogeneity (chi-squared p= 0.90, I 2 =0%).
Association between hypoglycaemia and falls or fractures (Figure 2)
There are four studies reporting on falls (Chiba et al., 2015) ( Signorovitch et al., 2013) with a pooled odds ratio of 1.89 (95% Confidence Interval 1.54, 2.32) and moderate heterogeneity (chi-squared p= 0.16, I 2 =43%).
We included three studies for fractures (Johnston et al., 2012) ( Rajpathak et al., 2015) with a pooled odds ratio of 1.92 (95% Confidence Interval 1.56, 2.38) and substantial heterogeneity (chi-squared p= 0.07, I 2 =63%).
Association between hypoglycaemia and mortality (Figure 3)
There are eight studies reporting on overall mortality with a pooled odds ratio of 2.04 (95% Confidence Interval 1.68, 2.47) with substantial heterogeneity (chisquared p< 0.001, I 2 =82%) (Bonds et al., 2010 , Hsu et al., 2013 , Origin Trial Investigators et al., 2013 , Khunti et al., 2015 , Majumdar et al., 2013 , McCoy et al., 2012 , Zhao et al., 2012 , Zoungas et al., 2010 . Despite the heterogeneity, we note that direction of association was consistent across all the studies in the Forest plot.
We explored the contribution of the specific studies to the heterogeneity, by removing single studies, one at a time, and we found that the only occasion where heterogeneity was markedly reduced (from 82% to 63%) was when Zhao's study was excluded. (Zhao et al., 2012) This is the only study that did not find a statistically significant association between hypoglycaemia and mortality (Hazard Ratio 1.29 with a 95% Confidence Interval 0.94, 1.77), which the authors attributed to small sample size (number of patients evaluated in the matched cohort was 1522).
We identified two studies that reported on the association between hypoglycaemia and a death due to a cardiovascular cause (Origin Trial Investigators et al., 2013) (Zoungas et al., 2010) . The pooled OR was 2.07 (95% Confidence Interval 1.34, 3.21) for this association.
Sensitivity Analysis
We aimed to clarify the temporal relationship between cardiovascular events and hypoglycaemia through a sensitivity analysis restricted to studies that excluded participants who had a history of recent macrovascular events. Pooled analysis of three studies showed that hypoglycaemia was significantly associated with newonset macrovascular events, OR 1.76 (1.42, 2.18).
Publication bias and selective outcome reporting
We did not construct a funnel plot, because we did not have more than ten studies for any specific outcome.
Discussion
Our meta-analysis of 17 observational studies (involving a total of almost 1.5 million participants) raises major concerns about a range of serious adverse events associated with hypoglycaemia in older patients treated with glucose-lowering drugs. We found consistent evidence of an 80% relative increase in the likelihood of vascular events (both macro-and microvascular complications, as well as cardiovascular death) with hypoglycemic episodes. Our meta-analysis also addresses previous uncertainties by revealing a significant relationship between hypoglycaemia and risk of falls and fractures, as well as a doubling in the likelihood of death. The abundance and consistency of evidence regarding serious harm leads us to believe that treatment strategies aimed at minimizing hypoglycaemia should be prioritized in older patients who are already prone to suffer from cardiovascular events, falls, and fractures.
There are a number of proposed biological mechanisms behind the adverse impact of hypoglycaemia on the cardiovascular system. Hypoglycaemia can lead to activation of the sympatho-adrenal system resulting in end-organ stimulation and release of adrenaline. This in turn provokes autonomic and hemodynamic changes resulting in an increased heart rate and peripheral systolic blood pressure, a fall in central blood pressure, reduced peripheral arterial resistance, increased myocardial
contractility, stroke volume and cardiac output (Frier et al., 2011 ) (Wright and Frier, 2008) . The effect of all of these physiological changes is cardiac stress, which can have potentially serious consequences (eg myocardial ischaemia) in older people with diabetes and likely underlying coronary artery disease. In addition, the first hypoglycemic episode can lead to further episodes that are asymptomatic and associated with cardiovascular and proarrhythmic changes (Zhao et al., 2012) .
Evidence has also shown that hypoglycaemia can result in abnormal electrical activity in the heart, strengthening the theory that hypoglycaemia can provoke sudden death (Frier et al., 2011) . Episodes of hypoglycaemia also result in impaired cardiac autonomic function which is associated with increased mortality among with patients at high cardiovascular risk, including those with diabetes (Zoungas et al., 2010) .
Interestingly, Yun et al have recently published the findings of a prospective cohort study demonstrating that a history of cardiovascular disease was an independent risk factor for the development of severe hypoglycaemia (Yun et al., 2015) . In order to assess the possibility of cardiovascular disease causing hypoglycaemia rather than the other way round, we conducted a sensitivity analysis based on studies that excluded patients with recent cardiovascular events. Our findings indicate that hypoglycaemia was associated with incident cardiovascular events, even in those patients with no cardiovascular history. Khunti et al. assessed the association between hypoglycaemia and cardiovascular events in subgroups of patients with, or without cardiovascular history, and found that the risk was similarly elevated in both subgroups, (Khunti et al., 2015) thus refuting Yun's hypothesis.
Alternatively, hypoglycaemia may simply be a surrogate marker/indicator for greater disease burden or frailty in older patients, and there may actually be no direct mechanistic pathway linking hypoglycaemia to cardiovascular events or death (Bonds et al., 2010 , Origin Trial Investigators et al., 2013 . However, Goto's review included a bias analysis which reported that comorbid severe illness alone would not be sufficient to explain the reported association between hypoglycaemia and cardiovascular disease. (Goto et al., 2013) Given the multi-factorial nature of adverse events in the elderly, it seems prudent to consider that hypoglycaemia may be one factor amongst a host of others that can contribute to serious harm, and that all efforts should be made to reduce this risk. It is also tempting to speculate whether hypoglycaemia episodes that trigger acute cardiovascular events may be the unifying factor in explaining the associated falls and increased mortality (particularly as our meta-analysis identified an increased likelihood of death from cardiovascular cause in patients with hypoglycaemia).
Strengths
Our systematic review and meta-analysis provides a comprehensive synthesis of the most up to date evidence covering a range of adverse events that are a major burden in older patients with diabetes. We have overcome the uncertainties regarding cardiovascular events and fall/fractures that were limitations within
Bloomfield's wide-ranging systematic review (Bloomfield et al., 2012) . We have further built upon Goto's cardiovascular-focused systematic review, (Goto et al., 2013) by including additional studies to distinguish between macrovascular and A C C E P T E D M A N U S C R I P T
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Limitations
We are aware of limitations in our meta-analyses, in particular the inability to prove causality due to the observational nature of the studies. However, we do not consider it ethical or feasible to conduct a randomized trial in older patients to expose them to hypoglycaemia. We chose to restrict our search to articles published in the past 10 years in order to focus on contemporary management of diabetes mellitus rather than more historical approaches, and our synthesis was restricted to
English-language articles only.
There is some heterogeneity, especially regarding the association between hypoglycaemia and mortality. This may stem from differences amongst the included study designs, which included post-hoc analyses of randomized controlled trials, in contrast to observational studies involving healthcare databases. We also noted considerable variation in the severity of disease and use of hypoglycaemic agents in the patients, and this may account for heterogeneity in subsequent risk of adverse events. Moreover, the included studies employed a very wide definition of adverse events, particularly when constructing a composite endpoint for vascular disease.
This stems from the variation in the use of administrative codes for the definition of cardiovascular events, as well as hypoglycaemia.
Our systematic review and meta-analysis highlights the importance of avoiding hypoglycaemia. This is especially true in older patients with diabetes mellitus and other co-morbidities, as they are at risk of serious adverse events associated with hypoglycemic episodes. Individualized treatment rather than achieving rigid targets should be a priority. This approach has recently also been highlighted by Caverley et al and coincides with the Department of Veterans' Affairs' launch of a hypoglycaemia safety initiative to decrease overtreatment among veterans with diabetes mellitus (Caverly et al., 2015) (Office of Public and Intergovernmental Affairs, 2014). Older patients and their physicians should aim to strike a pragmatic individualized balance between tight blood sugar control against the avoidance of adverse drug reactions, in particular hypoglycaemia and its associated serious harm.
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Multiple logistic regression
Confounders: patient demographics, baseline co-morbid conditions, baseline medications, CCI, medical encounters for diabetes, total baseline medical expenditures, number of medical codes aOR for fall-related fractures 1.70 (1.58, 1.83). Findings were similar for both the broad and narrow algorithm.
Kacharoo 2015 Admin claim data for fall-related events (ICD-9-CM codes for fractures and head injury, with fall being the external cause based on ICD-9-CM E-codes E880-E888 recorded within +/-2 days of each other in any order.
Admin claim data ICD-9-CM codes 250. Fall-related events (fractures, head injuries) defined using ICD-9-CM codes between 800.x-995.x, with a fall being the external cause (based on ICD-9-CM E-codes E880-E888 within twoday window). 
